Atyr Pharma Inc (ATYR) — 10-Q Filings

10-Q Filings (6)

• aTYR Pharma's Losses Widen Amid Soaring R&D Costs — Nov 6, 2025 Risk: high
  aTYR PHARMA INC reported a consolidated net loss of $25.7 million for the three months ended September 30, 2025, a significant increase from the $17.3 million l
• aTYR PHARMA Reports Flat Revenue, Widening Net Loss in Q2 — Aug 7, 2025 Risk: high
  aTYR PHARMA INC reported no license and collaboration revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The comp
• Atyr Pharma Files Q1 2025 10-Q — May 7, 2025 Risk: medium
  Atyr Pharma Inc. filed its 10-Q for the period ending March 31, 2025. The company, based in San Diego, CA, operates in the biological products sector. Key finan
• Atyr Pharma Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
  Atyr Pharma Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and operations. Key financial d
• Atyr Pharma Files 10-Q for Q2 2024 — Aug 13, 2024 Risk: medium
  Atyr Pharma Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business operations.
• aTYR PHARMA INC Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: medium
  aTYR PHARMA INC (ATYR) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. aTYR PHARMA INC filed a 10-Q report for the period ending March 31, 2024. Th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX